Title:
POLQ INHIBITOR COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/202623
Kind Code:
A1
Abstract:
Provided in the present invention are a POLQ inhibitor compound represented by formula (I) or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing same, and use thereof in preparing a drug for preventing or treating POLQ-mediated diseases.
Inventors:
LI ZHEN (CN)
TANG FENG (CN)
LIU LE (CN)
LIU LU (CN)
JIANG LEI (CN)
ZHOU FENG (CN)
LI ZHENGTAO (CN)
TANG RENHONG (CN)
REN JINSHENG (CN)
TANG FENG (CN)
LIU LE (CN)
LIU LU (CN)
JIANG LEI (CN)
ZHOU FENG (CN)
LI ZHENGTAO (CN)
TANG RENHONG (CN)
REN JINSHENG (CN)
Application Number:
PCT/CN2023/089240
Publication Date:
October 26, 2023
Filing Date:
April 19, 2023
Export Citation:
Assignee:
NANJING ZAIMING PHARMACEUTICAL CO LTD (CN)
International Classes:
A61K31/5377; C07D417/12; A61P35/00; C07D471/04
Domestic Patent References:
| WO2022259204A1 | 2022-12-15 | |||
| WO2023050007A1 | 2023-04-06 | |||
| WO2023060573A1 | 2023-04-20 | |||
| WO2023067515A1 | 2023-04-27 | |||
| WO2021028643A1 | 2021-02-18 |
Foreign References:
| CN114127062A | 2022-03-01 | |||
| TW202237595A | 2022-10-01 |
Other References:
DATABASE REGISTRY 8 November 2021 (2021-11-08), "STN search result"
Download PDF: